The FDA grants Breakthrough Therapy designation to the Usona Institute for its psilocybin therapy for major depressive disorder. Resource: Usona Institute
The FDA grants Breakthrough Therapy designation to the Usona Institute for its psilocybin therapy for major depressive disorder. Resource: Usona Institute